Does IXEKIZUMAB Cause Therapy cessation? 394 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 394 reports of Therapy cessation have been filed in association with IXEKIZUMAB (TALTZ). This represents 1.2% of all adverse event reports for IXEKIZUMAB.
394
Reports of Therapy cessation with IXEKIZUMAB
1.2%
of all IXEKIZUMAB reports
0
Deaths
27
Hospitalizations
How Dangerous Is Therapy cessation From IXEKIZUMAB?
Of the 394 reports, 27 (6.9%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 394 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which IXEKIZUMAB Alternatives Have Lower Therapy cessation Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID